首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >Durable Long-Term Remission with Allogeneic Hematopoietic Cell Transplantation (Ha) for Relapsed/Refractory Follicular Lymphoma (FL)

【24h】

Durable Long-Term Remission with Allogeneic Hematopoietic Cell Transplantation (Ha) for Relapsed/Refractory Follicular Lymphoma (FL)

机译：异基因造血细胞移植（Ha）对复发/难治性滤泡性淋巴瘤（FL）的持久长期缓解

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation》 |2016年第1期|共2页
作者
Jagadeesh Deepa; Rybicki Lisa; Abounader Donna; Dean Robert M.; Hill Brian; Liu Hien; Sobecks Ronald M.; Hamilton Betty Ky; Gerds Aaron; Ferraro Christina; Starn Jamie; Winslow Victoria; Pohlman Brad; Kalaycio Matt E.; Bolwell Brian; Majhail Navneet S.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Durable Long-Term Remission with Allogeneic Hematopoietic Cell Transplantation (Ha) for Relapsed/Refractory Follicular Lymphoma (FL) [J] . Jagadeesh Deepa, Rybicki Lisa, Abounader Donna, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2016,第3Suppla1期

机译：异基因造血细胞移植（Ha）对复发/难治性滤泡性淋巴瘤（FL）的持久长期缓解
2. Long-term follow-up of reduced-intensity allogeneic hematopoietic stem cell transplantation for refractory or relapsed follicular lymphoma? [J] . Yukako Ono, Takehiko Mori, Jun Kato Akiko Yamane Takayuki Shimizu Taku Kikuchi Sumiko Kohashi Shinichiro Okamoto AMERICAN JOURNAL OF HEMATOLOGY . 2012,第9期

机译：低强度异体造血干细胞移植治疗难治性或复发性滤泡性淋巴瘤的长期随访？
3. Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long-term disease control: an analysis from the Lymphoma Working Party of the EBMT [J] . Robinson S. P., Boumendil A., Finel H., Annals of oncology: official journal of the European Society for Medical Oncology . 2016,第6期

机译：自体移植后降低强度的同种异体干细胞移植治疗滤泡性淋巴瘤复发实现了长期的长期疾病控制：EBMT淋巴瘤工作组的分析
4. THE EFFECT OF INHIBITORY KILLER-CELL IG-LIKE RECEPTOR (IKIR) MATCHING IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT) [C] . David Senitzer, Joel Y. Sun, Arisa Oki, Clinical Histocompatibility Workshop. . 2009

机译：同种异体造血细胞移植（HCT）中抑制杀伤细胞IG样受体（IKIR）匹配的影响
5. Folate status and risk of relapse following allogeneic hematopoietic cell transplant for chronic myelogenous leukemia. [D] . Robien, Kimberly Ziemer. 2003

机译：异基因造血细胞移植治疗慢性粒细胞白血病后的叶酸状况和复发风险。
6. Durable Remission of Mantle Cell Lymphoma Relapsing a Third Time After Allogeneic Hematopoietic Stem Cell Transplantation Treated With Rituximab Bortezomib Donor Lymphocytes and Pegylated Interferon [O] . Phuong Vo, Elaine S. Jaffe, Lisa Cook, -1

机译：利妥昔单抗硼替佐米供体淋巴细胞和聚乙二醇化干扰素治疗同种异体造血干细胞移植后第三次复发的套细胞淋巴瘤持久缓解
7. Durable Long-Term Remission with Allogeneic Hematopoietic Cell Transplantation (HCT) for Relapsed/Refractory Follicular Lymphoma (FL) [O] . Deepa Jagadeesh, Lisa Rybicki, Donna Abounader, 2016

机译：具有同种异体造血细胞移植（HCT）的耐久的长期缓解，用于复发/难治性滤泡淋巴瘤（FL）

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号